CBSM Intervention Via mHealth to Ameliorate HIV-related Fatigue

Sponsor
Medical University of South Carolina (Other)
Overall Status
Completed
CT.gov ID
NCT03149094
Collaborator
National Institute of Nursing Research (NINR) (NIH)
30
1
2
14.1
2.1

Study Details

Study Description

Brief Summary

The purpose of this study is to create a smartphone, tablet and web-based application to help people deal with stress. Stress often increases fatigue in people with HIV infection, so successfully dealing with stress could help reduce HIV-related fatigue. The study is being done at one site, the Medical University of South Carolina. Approximately 30 people will take part in this portion of the study.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: CBSM-SMI
  • Behavioral: CBSM-SMI control
N/A

Detailed Description

For this study we will develop a fatigue symptom self-management cognitive behavioral stress management (CBSM) program that will be delivered via mHealth through smartphones and tablets (optimized for each). All CBSM content will be integrated into the application, but tailoring of information delivery will be derived through algorithm-driven feedback based on user input as they respond to integrated assessment and symptom monitoring questions. As a result, users of the CBSM-Self Management Intervention (CBSM-SMI) will receive personalized, relevant intervention content, when they need it, where they need it. This novel mode of CBSM delivery has not yet been provided via an mHealth format to HIV-infected individuals, despite its obvious advantages insofar as cost and reach are concerned.

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Feasibility and Acceptability of an mHealth Cognitive Behavioral Stress Management Intervention to Ameliorate HIV-related Fatigue
Actual Study Start Date :
Apr 27, 2017
Actual Primary Completion Date :
Mar 20, 2018
Actual Study Completion Date :
Jun 30, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: CBSM-SMI

The intervention group will receive Cognitive Behavioral Stress Management (CBSM) for Individuals Living with HIV via mHealth through smartphones and tablets.

Behavioral: CBSM-SMI
The intervention group will receive Cognitive Behavioral Stress Management (CBSM) for Individuals Living with HIV via mHealth through smartphones and tablets.

Active Comparator: CBSM-SMI control

The control group will receive an app called LifeSum, which focuses on healthy lifestyles.

Behavioral: CBSM-SMI control
this group will receive the LifeSum app.

Outcome Measures

Primary Outcome Measures

  1. Feasibility and Acceptability Scale [Baseline]

    The Feasibility and Acceptability Scale is a 5 item, 5-point scale, developed to assess the feasibility and acceptability of interventions.

  2. Feasibility and Acceptability Scale [10 weeks]

    The Feasibility and Acceptability Scale is a 5 item, 5-point scale, developed to assess the feasibility and acceptability of interventions.

  3. Feasibility and Acceptability Scale [22 weeks]

    The Feasibility and Acceptability Scale is a 5 item, 5-point scale, developed to assess the feasibility and acceptability of interventions.

Secondary Outcome Measures

  1. HIV-Related Fatigue Scale (HRFS) [Baseline]

    The HRFS is a 56-item instrument which assesses fatigue severity, responsiveness to self-care, and fatigue-related impairment of functioning in HIV infection.

  2. HIV-Related Fatigue Scale (HRFS) [5 weeks]

    The HRFS is a 56-item instrument which assesses fatigue severity, responsiveness to self-care, and fatigue-related impairment of functioning in HIV infection.

  3. HIV-Related Fatigue Scale (HRFS) [10 weeks]

    The HRFS is a 56-item instrument which assesses fatigue severity, responsiveness to self-care, and fatigue-related impairment of functioning in HIV infection.

  4. HIV-Related Fatigue Scale (HRFS) [22 weeks]

    The HRFS is a 56-item instrument which assesses fatigue severity, responsiveness to self-care, and fatigue-related impairment of functioning in HIV infection.

  5. PROMIS Short Form - Fatigue 8a [Baseline]

    The PROMIS Fatigue 8a evaluates a range of self-reported symptoms, from mild subjective feelings of tiredness to an overwhelming, debilitating, and sustained sense of exhaustion that likely decreases one's ability to execute daily activities and function normally in family or social role.

  6. PROMIS Short Form - Fatigue 8a [5 weeks]

    The PROMIS Fatigue 8a evaluates a range of self-reported symptoms, from mild subjective feelings of tiredness to an overwhelming, debilitating, and sustained sense of exhaustion that likely decreases one's ability to execute daily activities and function normally in family or social role.

  7. PROMIS Short Form - Fatigue 8a [10 weeks]

    The PROMIS Fatigue 8a evaluates a range of self-reported symptoms, from mild subjective feelings of tiredness to an overwhelming, debilitating, and sustained sense of exhaustion that likely decreases one's ability to execute daily activities and function normally in family or social role.

  8. PROMIS Short Form - Fatigue 8a [22 weeks]

    The PROMIS Fatigue 8a evaluates a range of self-reported symptoms, from mild subjective feelings of tiredness to an overwhelming, debilitating, and sustained sense of exhaustion that likely decreases one's ability to execute daily activities and function normally in family or social role.

  9. The State Trait Anxiety Inventory (STAI)-State [Baseline]

    The STAI is a self-report measure of state anxiety, consisting of 20 emotion descriptor items; respondents indicate how they are feeling right now by rating each item on a 4-point scale.

  10. The State Trait Anxiety Inventory (STAI)-State [5 weeks]

    The STAI is a self-report measure of state anxiety, consisting of 20 emotion descriptor items; respondents indicate how they are feeling right now by rating each item on a 4-point scale.

  11. The State Trait Anxiety Inventory (STAI)-State [10 weeks]

    The STAI is a self-report measure of state anxiety, consisting of 20 emotion descriptor items; respondents indicate how they are feeling right now by rating each item on a 4-point scale.

  12. The State Trait Anxiety Inventory (STAI)-State [22 weeks]

    The STAI is a self-report measure of state anxiety, consisting of 20 emotion descriptor items; respondents indicate how they are feeling right now by rating each item on a 4-point scale.

  13. Beck Depression Inventory (BDI-II) [Baseline]

    The BDI-II is a 21 item measure of depressive severity with higher total scores indicative of more severe depression.

  14. Beck Depression Inventory (BDI-II) [5 weeks]

    The BDI-II is a 21 item measure of depressive severity with higher total scores indicative of more severe depression.

  15. Beck Depression Inventory (BDI-II) [10 weeks]

    The BDI-II is a 21 item measure of depressive severity with higher total scores indicative of more severe depression.

  16. Beck Depression Inventory (BDI-II) [22 weeks]

    The BDI-II is a 21 item measure of depressive severity with higher total scores indicative of more severe depression.

  17. Life Experiences Scale [Baseline]

    The Life Experiences Scale is a 30-item self-report measure that allows respondents to indicate recent stressful life events.

  18. Life Experiences Scale [5 weeks]

    The Life Experiences Scale is a 30-item self-report measure that allows respondents to indicate recent stressful life events.

  19. Life Experiences Scale [10 weeks]

    The Life Experiences Scale is a 30-item self-report measure that allows respondents to indicate recent stressful life events.

  20. Life Experiences Scale [22 weeks]

    The Life Experiences Scale is a 30-item self-report measure that allows respondents to indicate recent stressful life events.

  21. CD4 count from the medical record [Baseline]

    A CD4 count is a lab test that measures the number of CD4 T lymphocytes (CD4 cells) in a sample of blood. In people with HIV, it is the most important laboratory indicator of how well the immune system is working and the strongest predictor of HIV progression.

  22. CD4 count from the medical record [22 weeks]

    A CD4 count is a lab test that measures the number of CD4 T lymphocytes (CD4 cells) in a sample of blood. In people with HIV, it is the most important laboratory indicator of how well the immune system is working and the strongest predictor of HIV progression.

  23. HIV viral load information from the medical record [Baseline]

    A viral load test is a lab test that measures the number of HIV virus particles in a milliliter of blood. A viral load test helps provide information on how well antiretroviral therapy is controlling the virus.

  24. HIV viral load information from the medical record [22 weeks]

    A viral load test is a lab test that measures the number of HIV virus particles in a milliliter of blood. A viral load test helps provide information on how well antiretroviral therapy is controlling the virus.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • HIV positive

  • Reads and understands English

  • Scores greater than 5 on the HIV-Related Fatigue Scale

  • Mentally competent to give informed consent

Exclusion Criteria:
  • Co-morbid conditions marked by fatigue (e.g., renal disease, cancer, multiple sclerosis)

  • Pregnant women and women who are less than 1 year postpartum

  • Active psychosis or dementia

  • Suicidal ideation with clear intent

  • Current substance dependence

Contacts and Locations

Locations

Site City State Country Postal Code
1 Medical University of South Carolina Charleston South Carolina United States 29425

Sponsors and Collaborators

  • Medical University of South Carolina
  • National Institute of Nursing Research (NINR)

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Medical University of South Carolina
ClinicalTrials.gov Identifier:
NCT03149094
Other Study ID Numbers:
  • Pro00057504
  • 1P20NR016575-01
First Posted:
May 11, 2017
Last Update Posted:
Jul 18, 2018
Last Verified:
Jul 1, 2018
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Medical University of South Carolina
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 18, 2018